CLAI.L Stock - Cel AI PLC
Unlock GoAI Insights for CLAI.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $17,942 | $67,236 | $28,904 | N/A | N/A |
| Gross Profit | $10,259 | $41,440 | $18,117 | N/A | N/A |
| Gross Margin | 57.2% | 61.6% | 62.7% | N/A | N/A |
| Operating Income | $-1,848,981 | $-3,333,739 | $-5,991,000 | $-3,334,000 | $-330,000 |
| Net Income | $-1,827,461 | $-3,309,721 | $-5,990,000 | $-3,334,000 | $-330,000 |
| Net Margin | -10185.4% | -4922.5% | -20723.8% | N/A | N/A |
| EPS | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.00 |
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United Kingdom.
Visit WebsiteEarnings History & Surprises
CLAI.LLatest News
Frequently Asked Questions about CLAI.L
What is CLAI.L's current stock price?
What is the analyst price target for CLAI.L?
What sector is Cel AI PLC in?
What is CLAI.L's market cap?
Does CLAI.L pay dividends?
Similar Stocks
Consumer Defensive SectorExplore stocks similar to CLAI.L for comparison